ISSCR News

The ISSCR Welcomes New Vice President, Treasurer, Clerk, and Directors
The International Society for Stem Cell Research (ISSCR) is pleased to announce the results of its 2025 election and to welcome new leaders to the ISSCR Executive Committee and Board of Directors.

Three Stem Cell Scientists Earn Poster Awards at ISSCR’s Athens International Symposium on Neural Stem Cells
The International Society of Stem Cell Research (ISSCR) is pleased to recognize Alice Rossi, PhD, Francis Crick Institute, UK, Angeliki Spathopoulou, PhD, University of Innsbruck, Austria, and Gareth D. Chapman, PhD, Washington University in St. Louis, USA, with the ISSCR Athens International Symposium Outstanding Poster Award.

ISSCR Honors Volunteer Leaders with the 2025 ISSCR Public Service Award
Recognizing the commitment and talent of all International Society for Stem Cell Research (ISSCR) volunteer leaders, the ISSCR Executive Committee is honoring members of committees, taskforces, and working groups who dedicate tremendous talent and dedication to the ISSCR and its mission with the 2025 ISSCR Public Service Award. This is the first group award in the Society’s history and indicative of the ISSCR commitment to celebrate the excellence that fuels the tremendous accomplishments of the foremost global organization dedicated to stem cell science and regenerative medicine.

ISSCR Journal Stem Cell Reports Named Official Conference Journal for BaCell 3D Conference
Stem Cell Reports, the premier open-access journal dedicated to advancing stem cell research, has been named the official conference journal for BaCell 3D, taking place from 23-25 June 2025, in Basel, Switzerland.

Stem Cell Transplant Clears Clinical Safety Hurdle for the Treatment of Wet Age-Related Macular Degeneration
Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced stages. A new, alternative treatment for those patients may be surgical removal of the abnormal blood vessels followed by the transplantation of stem cell-derived retinal cells, according to a recent study led by Yong Liu and colleagues from Third Military Medical University Southwest Hospital, China, published in the journal Stem Cell Reports.

Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .